Molecular insights into the surface-specific arrangement of complement C5 convertase enzymes
- PMID: 26552476
- PMCID: PMC4638095
- DOI: 10.1186/s12915-015-0203-8
Molecular insights into the surface-specific arrangement of complement C5 convertase enzymes
Abstract
Background: Complement is a large protein network in plasma that is crucial for human immune defenses and a major cause of aberrant inflammatory reactions. The C5 convertase is a multi-molecular protease complex that catalyses the cleavage of native C5 into its biologically important products. So far, it has been difficult to study the exact molecular arrangement of C5 convertases, because their non-catalytic subunits (C3b) are covalently linked to biological surfaces through a reactive thioester. Through development of a highly purified model system for C5 convertases, we here aim to provide insights into the surface-specific nature of these important protease complexes.
Results: Alternative pathway (AP) C5 convertases were generated on small streptavidin beads that were coated with purified C3b molecules. Site-specific biotinylation of C3b via the thioester allowed binding of C3b in the natural orientation on the surface. In the presence of factor B and factor D, these C3b beads could effectively convert C5. Conversion rates of surface-bound C3b were more than 100-fold higher than fluid-phase C3b, confirming the requirement of a surface. We determine that high surface densities of C3b, and its attachment via the thioester, are essential for C5 convertase formation. Combining our results with molecular modeling explains how high C3b densities may facilitate intermolecular interactions that only occur on target surfaces. Finally, we define two interfaces on C5 important for its recognition by surface-bound C5 convertases.
Conclusions: We establish a highly purified model that mimics the natural arrangement of C5 convertases on a surface. The developed model and molecular insights are essential to understand the molecular basis of deregulated complement activity in human disease and will facilitate future design of therapeutic interventions against these critical enzymes in inflammation.
Figures






Similar articles
-
Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models.Front Immunol. 2018 Jul 23;9:1691. doi: 10.3389/fimmu.2018.01691. eCollection 2018. Front Immunol. 2018. PMID: 30083158 Free PMC article.
-
C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.J Immunol. 1988 Dec 1;141(11):3895-901. J Immunol. 1988. PMID: 3183384
-
Formation of high-affinity C5 convertases of the alternative pathway of complement.J Immunol. 2001 Feb 15;166(4):2635-42. doi: 10.4049/jimmunol.166.4.2635. J Immunol. 2001. PMID: 11160326
-
Structure/function of C5 convertases of complement.Int Immunopharmacol. 2001 Mar;1(3):415-22. doi: 10.1016/s1567-5769(00)00039-4. Int Immunopharmacol. 2001. PMID: 11367526 Review.
-
Structure and function of complement C5 convertase enzymes.Biochem Soc Trans. 2002 Nov;30(Pt 6):1006-10. doi: 10.1042/bst0301006. Biochem Soc Trans. 2002. PMID: 12440962 Review.
Cited by
-
An inhibitor of complement C5 provides structural insights into activation.Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):362-370. doi: 10.1073/pnas.1909973116. Epub 2019 Dec 23. Proc Natl Acad Sci U S A. 2020. PMID: 31871188 Free PMC article.
-
Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1.Sci Rep. 2023 Jan 6;13(1):274. doi: 10.1038/s41598-022-27279-4. Sci Rep. 2023. PMID: 36609665 Free PMC article.
-
Group IIA-Secreted Phospholipase A2 in Human Serum Kills Commensal but Not Clinical Enterococcus faecium Isolates.Infect Immun. 2018 Jul 23;86(8):e00180-18. doi: 10.1128/IAI.00180-18. Print 2018 Aug. Infect Immun. 2018. PMID: 29784864 Free PMC article.
-
Acquired drivers of C3 glomerulopathy.Clin Kidney J. 2025 Jan 27;18(3):sfaf022. doi: 10.1093/ckj/sfaf022. eCollection 2025 Mar. Clin Kidney J. 2025. PMID: 40052168 Free PMC article. Review.
-
Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.Front Immunol. 2019 Jun 17;10:1350. doi: 10.3389/fimmu.2019.01350. eCollection 2019. Front Immunol. 2019. PMID: 31263464 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous